Inventor · disambiguated record
Manami Shizuka
Also filed as: SHIZUKA MANAMI
30 granted patents·11 pending applications·54 citations·filing 2010–2023
96Inventor score
Top patents by PatentIndex Score
41 records- 0193US9381256B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Jul 5, 2016·12 cites·20 claims
- 0291US10787463B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Sep 29, 2020·1 cites·25 claims
- 0390US10081640B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Sep 25, 2018·5 cites·18 claims
- 0489US11390633B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Jul 19, 2022·1 cites·9 claims
- 0589US10385071B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Aug 20, 2019·3 cites·19 claims
- 0688US10844078B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Nov 24, 2020·2 cites·20 claims
- 0788US10370389B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted Aug 6, 2019·3 cites·22 claims
- 0888US9669102B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·5 cites·28 claims
- 0988US2023257400A1Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 1087US9873708B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Jan 23, 2018·3 cites·22 claims
- 1186US10442809B2Methods for preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-6-onesIMMUNOGEN INC·Filed 2018·Granted Oct 15, 2019·2 cites·15 claims
- 1285US10238751B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted Mar 26, 2019·3 cites·20 claims
- 1385US9890179B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Feb 13, 2018·2 cites·19 claims
- 1482US10968228B2Methods of preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indolesIMMUNOGEN INC·Filed 2019·Granted Apr 6, 2021·1 cites·20 claims
- 1582US2024067652A1Method of preparing indolinobenzodiazepine derivativesIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 1681US2023233697A1Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 1780US11981687B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Granted May 14, 2024·0 cites·23 claims
- 1879US11420982B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Aug 23, 2022·0 cites·20 claims
- 1979US10899775B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Jan 26, 2021·0 cites·22 claims
- 2079US2021171547A1Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Application pending·0 cites
- 2178US10722588B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Jul 28, 2020·1 cites·17 claims
- 2277US9682978B22,6,7 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 20, 2017·2 cites·10 claims
- 2376US9974867B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted May 22, 2018·1 cites·20 claims
- 2476US2024190956A1Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 2575US10988531B2Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2015·Granted Apr 27, 2021·1 cites·11 claims
- 2675US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 2775US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 2874US2024197898A1SUBSTITUTED BENZO[5,6][1,4]DIAZEPINO[1,2-a]INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISORDERSIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 2973US11116845B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Sep 14, 2021·0 cites·15 claims
- 3072US11760759B2Process for preparing substituted indolinesIMMUNOGEN INC·Filed 2021·Granted Sep 19, 2023·0 cites·11 claims
- 3172US2020017526A1Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 3270US11732038B2Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2021·Granted Aug 22, 2023·0 cites·6 claims
- 3370US10392407B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Aug 27, 2019·0 cites·22 claims
- 3470US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 3565US8859776B2Substituted piperidines that increase p53 activity and the uses thereofBOGEN STEPHANE L·Filed 2010·Granted Oct 14, 2014·2 cites·44 claims
- 3664US11793885B2Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disordersIMMUNOGEN INC·Filed 2018·Granted Oct 24, 2023·0 cites·12 claims
- 3751US2016367698A1Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Application pending·0 cites
- 3850US2023094471A1Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhibiting abnormal cell growth or for treating proliferative diseasesIMMUNOGEN INC·Filed 2020·Application pending·0 cites
- 3950US2014336222A1SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOFMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4049US2018346488A1Cytotoxic benzodiazepine derivatives and conjugates thereofIMMUNOGEN INC·Filed 2018·Application pending·0 cites
- 4142US9062071B2Substituted piperidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Jun 23, 2015·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Manami Shizuka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →